Form 4 for NMTC NEUROONE MEDICAL TECHNOLOGIES Corp
Accepted 2026-02-20 00:00:00 ET · period of report 2026-02-18 · accession 0001540354-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-20 | 2026-02-18 | NMTC | Rosa David A | CEO, Pres, Dir | F - Tax | $0.68 | -71.3K | 1.08M | -6% | -$48.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-18 | F | D | 71,325 | $0.68 | 1,082,590 | D | — | — |